These data confirm the debilitating effects of apathy on functioning in patients with Huntington disease.
The authors noted that apathy is very common and progressive among Huntington disease mutation carriers, even during early stages of the disease, and has been associated with decline in general functioning.
Electrical stimulation of the amygdala may boost declarative memory without influencing an emotional response.
The HD-associated CAG repeat with 36 or more repeats was found in 18 individuals.
The FDA has accepted Teva's New Drug Application for deutetrabenazine to treat chorea associated with Huntington's disease.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Rapid Cycling Bipolar Disorder Associated With ADHD and Female Gender
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Symptom Trajectories Vary According to Language Development in Autism
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children
- Addressing the Uncertainties of the Public Service Loan Forgiveness Program for Medical School Graduates
- Leana Wen, MD, to Assume Planned Parenthood Presidency
- Nomophobia: The Modern-Day Pathology